论文部分内容阅读
无症状乙肝病毒携带者，目前尚无特效治疗方法。自1976年Greenberg首次用天然白细胞干扰素治疗慢性乙型肝炎获得一定疗效以来，干扰素（IFN）被临床工作者所重视[1]。为了探索人血白细胞IFN治疗乙肝病毒携带者的适当剂量，本文用不同剂量的人白细胞IFN治疗无症状乙肝病毒携带者
Asymptomatic hepatitis B virus carriers, there is no effective treatment. Interferon (IFN) has been valued by clinicians since 1976 when Greenberg first achieved a therapeutic effect in the treatment of chronic hepatitis B with natural leukocyte interferon [1]. In order to explore the appropriate dose of human leukocyte IFN treatment of hepatitis B virus carriers, this article with different doses of human leukocyte IFN treatment of asymptomatic hepatitis B virus carriers